Literature DB >> 32052415

Emulation Differences vs. Biases When Calibrating Real-World Evidence Findings Against Randomized Controlled Trials.

Jessica M Franklin1, Robert J Glynn1, Samy Suissa2, Sebastian Schneeweiss1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32052415      PMCID： PMC7233792          DOI： 10.1002/cpt.1793

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  9 in total

1.  Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride.

Authors:  Elisabetta Patorno; Sebastian Schneeweiss; Chandrasekar Gopalakrishnan; David Martin; Jessica M Franklin
Journal:  Diabetes Care       Date:  2019-06-25       Impact factor: 19.112

2.  Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available.

Authors:  Miguel A Hernán; James M Robins
Journal:  Am J Epidemiol       Date:  2016-03-18       Impact factor: 4.897

3.  Claims-based studies of oral glucose-lowering medications can achieve balance in critical clinical variables only observed in electronic health records.

Authors:  Elisabetta Patorno; Chandrasekar Gopalakrishnan; Jessica M Franklin; Kimberly G Brodovicz; Elvira Masso-Gonzalez; Dorothee B Bartels; Jun Liu; Sebastian Schneeweiss
Journal:  Diabetes Obes Metab       Date:  2018-01-12       Impact factor: 6.577

Review 4.  Nonrandomized Real-World Evidence to Support Regulatory Decision Making: Process for a Randomized Trial Replication Project.

Authors:  Jessica M Franklin; Ajinkya Pawar; David Martin; Robert J Glynn; Mark Levenson; Robert Temple; Sebastian Schneeweiss
Journal:  Clin Pharmacol Ther       Date:  2019-10-25       Impact factor: 6.875

5.  Participation in a clinical trial enhances adherence and persistence to treatment: a retrospective cohort study.

Authors:  Hein A W van Onzenoort; Frederique E Menger; Cees Neef; Willem J Verberk; Abraham A Kroon; Peter W de Leeuw; Paul-Hugo M van der Kuy
Journal:  Hypertension       Date:  2011-08-08       Impact factor: 10.190

6.  Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial.

Authors:  Julio Rosenstock; Steven E Kahn; Odd Erik Johansen; Bernard Zinman; Mark A Espeland; Hans J Woerle; Egon Pfarr; Annett Keller; Michaela Mattheus; David Baanstra; Thomas Meinicke; Jyothis T George; Maximilian von Eynatten; Darren K McGuire; Nikolaus Marx
Journal:  JAMA       Date:  2019-09-24       Impact factor: 56.272

7.  ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.

Authors:  Jonathan Ac Sterne; Miguel A Hernán; Barnaby C Reeves; Jelena Savović; Nancy D Berkman; Meera Viswanathan; David Henry; Douglas G Altman; Mohammed T Ansari; Isabelle Boutron; James R Carpenter; An-Wen Chan; Rachel Churchill; Jonathan J Deeks; Asbjørn Hróbjartsson; Jamie Kirkham; Peter Jüni; Yoon K Loke; Theresa D Pigott; Craig R Ramsay; Deborah Regidor; Hannah R Rothstein; Lakhbir Sandhu; Pasqualina L Santaguida; Holger J Schünemann; Beverly Shea; Ian Shrier; Peter Tugwell; Lucy Turner; Jeffrey C Valentine; Hugh Waddington; Elizabeth Waters; George A Wells; Penny F Whiting; Julian Pt Higgins
Journal:  BMJ       Date:  2016-10-12

Review 8.  Are Novel, Nonrandomized Analytic Methods Fit for Decision Making? The Need for Prospective, Controlled, and Transparent Validation.

Authors:  Hans-Georg Eichler; Franz Koenig; Peter Arlett; Harald Enzmann; Anthony Humphreys; Frank Pétavy; Brigitte Schwarzer-Daum; Bruno Sepodes; Spiros Vamvakas; Guido Rasi
Journal:  Clin Pharmacol Ther       Date:  2019-10-01       Impact factor: 6.875

9.  Using Electronic Health Records to Derive Control Arms for Early Phase Single-Arm Lung Cancer Trials: Proof-of-Concept in Randomized Controlled Trials.

Authors:  Gillis Carrigan; Samuel Whipple; William B Capra; Michael D Taylor; Jeffrey S Brown; Michael Lu; Brandon Arnieri; Ryan Copping; Kenneth J Rothman
Journal:  Clin Pharmacol Ther       Date:  2019-10-11       Impact factor: 6.875
  9 in total
  3 in total

1.  Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative.

Authors:  Jessica M Franklin; Elisabetta Patorno; Rishi J Desai; Robert J Glynn; David Martin; Kenneth Quinto; Ajinkya Pawar; Lily G Bessette; Hemin Lee; Elizabeth M Garry; Nileesa Gautam; Sebastian Schneeweiss
Journal:  Circulation       Date:  2020-12-17       Impact factor: 29.690

2.  Postapproval trials versus patient registries: comparability of advanced melanoma patients with brain metastases.

Authors:  Rawa K Ismail; Nienke O Sikkes; Michel W J M Wouters; Doranne L Hilarius; Anna M G Pasmooij; Alfonsus J M van den Eertwegh; Maureen J B Aarts; Franchette W P J van den Berkmortel; Marye J Boers-Sonderen; Jan Willem B de Groot; John B A G Haanen; Geke A P Hospers; Ellen Kapiteijn; Djura Piersma; Roos S van Rijn; Karijn P M Suijkerbuijk; Bert-Jan Ten Tije; Astrid A M van der Veldt; Art Vreugdenhil; Maaike van Dartel; Anthonius de Boer
Journal:  Melanoma Res       Date:  2021-02-01       Impact factor: 3.199

Review 3.  Drug Dosing Recommendations for All Patients: A Roadmap for Change.

Authors:  J Robert Powell; Jack Cook; Yaning Wang; Richard Peck; Dan Weiner
Journal:  Clin Pharmacol Ther       Date:  2020-07-12       Impact factor: 6.903
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.